Abdallah Hamdallah
Clinical Neurophysiology · Palos Heights, ILNPI 1053726760
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.0% of the total across 562 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 47 manufacturers, the largest accounting for just 15.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $3,722, more than ten times the $200 reported in 2019.
Across 562 payments — averaging $21.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- UCB, Inc.$1K
- Livanova USA, Inc.$960
- Novartis$911
- Biogen$662
- Teva Pharmaceuticals USA, Inc.$614
- plus $6K from 41 others
What the payments were for
- Travel & lodging$2102%
- Food & beverage$12,04198%
- Education$330%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VNS Therapy$496
How this compares
Too few clinical neurophysiology providers in Illinoisto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| UbrelvyUbrogepant | 30 | $46,375 |
| Emgality PenGalcanezumab-Gnlm | 47 | $43,929 |
| QuliptaAtogepant | 29 | $38,604 |
| AptiomEslicarbazepine Acetate | 19 | $37,179 |
| Levetiracetam | 580 | $30,737 |
| FycompaPerampanel | 30 | $27,698 |
| Lacosamide | 174 | $23,729 |
| BriviactBrivaracetam | 15 | $21,311 |
| Nurtec OdtRimegepant Sulfate | 19 | $19,545 |
| XcopriCenobamate | 13 | $14,916 |
| NayzilamMidazolam | 21 | $13,519 |
| Carbamazepine | 76 | $7,008 |
| Carbamazepine ErCarbamazepine | 81 | $6,990 |
| Breo ElliptaFluticasone/Vilanterol | 13 | $6,801 |
| Oxcarbazepine | 44 | $5,054 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieUbrelvy, Qulipta | $1,872 | $84,97959 claims |
| UCB, Inc.Briviact, Nayzilam | $1,222 | $34,83036 claims |
| Eisai Inc.Fycompa | $198 | $27,69830 claims |
| PfizerNurtec Odt, Dilantin | $525 | $20,65432 claims |
| SK Life Science, Inc.Xcopri | $365 | $14,91613 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few clinical neurophysiology providers in Illinoison file to place this against a meaningful peer group, so we don't.
Other clinical neurophysiology in Palos Heights
- Micheal MackenChicago$555K
- Sumayyah AbumuradChicago$85K
- Akash PatelChicago$10K
- Clarissa LiewChampaign$9K
- Zeina RabiHinsdale$7K
- Mir YadullahiChicago$2K
- Abdullah AlamChicago$2K
- Delphi BaruaDecatur$982
- Suemin YoonLake Forest$532
- Diana MnatsakanovaChicago$375
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.